A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

First results of the PRIMARY2 randomized phase III trial support consideration of PSMA PET/CT in diagnostic work-up ...

March is Colorectal Cancer Awareness Month and an ideal time to focus on the third most common cancer in the U.S. Many people know the importance of ...

Ricky Gervais' longtime partner Jane Fallon shared that she had been diagnosed with breast cancer earlier this year, but was ...

They use the body's own immune system to detect and kill cancer cells "Immunotherapies have been very promising and has ...

Ed Sheeran offered an update on his wife Cherry Seaborn, who was diagnosed with cancer in 2022 while pregnant with their ...

Ed Sheeran offered an update on his wife Cherry Seaborn, who was diagnosed with cancer in 2022 while pregnant with their second baby girl.

A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.

Thirty-six progressive mCRPC patients received TLX591-Tx across three cohorts (enzalutamide, abiraterone, or docetaxel sequence), and all completed two planned doses without emergent, unexpected ...

An important clinical trial announcement is good news for this healthcare stock. The post Bell Potter is tipping this exciting ASX healthcare stock to rise 80% appeared first on The Motley Fool ...